Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Leases: 2016-2018

Historic Capital Leases for Editas Medicine (EDIT) over the last 3 years, with Dec 2018 value amounting to $32.4 million.

  • Editas Medicine's Capital Leases fell 3.03% to $32.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $32.4 million, marking a year-over-year decrease of 3.03%. This contributed to the annual value of $32.4 million for FY2018, which is 3.03% down from last year.
  • As of FY2018, Editas Medicine's Capital Leases stood at $32.4 million, which was down 3.03% from $33.4 million recorded in FY2017.
  • In the past 5 years, Editas Medicine's Capital Leases ranged from a high of $35.1 million in FY2016 and a low of $32.4 million during FY2018.
  • Over the past 3 years, Editas Medicine's median Capital Leases value was $33.4 million (recorded in 2017), while the average stood at $33.6 million.
  • Data for Editas Medicine's Capital Leases shows a maximum YoY decreased of 4.74% (in 2017) over the last 5 years.
  • Yearly analysis of 3 years shows Editas Medicine's Capital Leases stood at $35.1 million in 2016, then dropped by 4.74% to $33.4 million in 2017, then declined by 3.03% to $32.4 million in 2018.